IRCT20150107020592N22招募中3 期
Cyclosporin for the Prevention and Treatment of COVID-19 Disease
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •covid patients
- •non-intubated payients
- •Age between 18-80
排除标准
- •Allergy to cyclosporin
- •intubated patients
研究者
相似试验
已完成
不适用
Efficacy of cyclosporine therapy in the treatment of non-severe aplastic anemiaaplastic anemiaJPRN-UMIN000030453Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu34
已完成
不适用
The clinical effects and safty of cyclosporine with rootine corticosteroid treatment in onset MCNSminimal change nephrotic syndromeJPRN-UMIN000004653Yokohama city university graduate school of medicine20
尚未招募
4 期
The CO-POC trialCOlchicine for the prevention of Peri-Operative Complications: A prospective randomised placebo controlled, double blinded study to assess the role of colchicine in decreasing myocardial injury during cardiac surgeryMyocardial injuryCoronary artery bypass surgeryPost-pericardiotomy syndromePost-operative atrial fibrillationPost-operative effusionsACTRN12617000203358Sydney Local Health District204
已完成
不适用
Searching for the optimal cyclosporin A treatment method for atopic dermatitisatopic dermatitisJPRN-UMIN000004284Osaka univeristy40
已完成
不适用
Efficacy and safety of cyclosporine and steroid for the treatment of minimal change nephrotic syndromeMinimal change nephrotic syndromeJPRN-UMIN000000963Yoshihiko Saito30